Comparison of chromosomal imbalances in neuroendocrine and non-small- cell lung carcinomas

Cancer Genetics and Cytogenetics

Volumn 114, Issue 1, 1999, Pages 22-30

  Michelland, Sylvie ^a   Gazzeri, Sylvie ^a   Brambilla, Elisabeth ^a   Robert Nicoud, Michel ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; KARYOTYPE; LUNG NON SMALL CELL CANCER; NEUROENDOCRINE TUMOR; PHENOTYPE; PRIORITY JOURNAL;

CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOME ABERRATIONS; GENE FREQUENCY; LUNG NEOPLASMS; NEUROENDOCRINE TUMORS;

EID: 0032864498     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00035-7     Document Type: Article

References (47)

1. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics. Cancer J Clin. 46:1996;5-27.
2. Travis W.D., Linnoila R.I., Tsokos M.G., Hitchcock C.L., Cutler G.B., Nieman L., Chrousos G., Pass H., Doppman J. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. Am J Surg Pathol. 15:1991;529-553.
3. Whang Peng J., Kao-shan C.S., Lee E.C., Bunn P.A., Carney D.N., Gazdar A.F., Minna J.D. Specific chromosome defect associated with human small-cell lung cancer. Science. 215:1982;181-182.
4. Miura I., Graziano S.L., Cheng J.Q., Doyle I.A., Testa J.R. Chromosome alterations in human small cell lung cancer. Frequent involvement of 5q Cancer Res. 52:1992;1322-1328.
5. Bepler G., Garcia-Blanco M.A. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc Natl Acad Sci USA. 91:1994;5513-5517.
6. Yakota J., Wada M., Shimosato Y., Terada M., Sugimura T. Loss of heterozygosity on chromosomes 3, 13 and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA. 84:1987;9252-9256.
7. Ried T., Petersen I., Holtgreve-Grez H., Speicher M.R., Schröck E., Du Manoir S., Cremer T. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 54:1994;1801-1806.
8. Minna J.D., Sekido Y., Fong K., Gazdar A.F. Molecular biology of lung cancer. Devita V.T., Hellman S., Rosenberg S.A. Cancer. Principles and Practice of Oncology:1997;849-857 Lippincott-Raven, Philadelphia.
9. Heim S., Mitelman F. Cancer Cytogenetics. 1995;Wiley-Liss, New York.
10. Kallioniemi A., Kallioniemi O.P., Sudar D., Rutovitz D., Gray J.W., Waldman F., Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
11. Du Manoir S., Speicher M.R., Joos S., Schröck E., Popp S., Döhner H., Kovacs G., Robert-Nicoud M., Lichter P., Cremer T. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet. 90:1993;590-610.
12. Brambilla E., Moro D., Veale D., Brichon P.Y., Stoebner P., Paramelle B., Brambilla C. Basaloid carcinomas of lung. a new phenotypic entity with prognosis significance Hum Pathol. 23:1992;993-1003.
13. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer. 10:1994;231-243.
14. Sambrook J, Fritsch EF, Maniatis T (1989): Molecular cloning: A laboratory manual.
15. Jolly C., Michelland S., Rocchi M., Robert-Nicoud M., Vourc'h C. Analysis of the transcriptional activity of amplified genes in tumor cells by fluorescence in situ hybridization. Hum Genet. 101:1997;81-87.
16. Testa J.R., Liu Z., Feder M., Bell D.W., Balsara B., Quan Cheng J., Taguchi T. Advances in the analysis of chromosomal alterations in human lung carcinomas. Cancer Genet Cytogenet. 95:1997;20-32.
17. Levin N.A., Brzoska P.M., Warnock M.L., Gray J.W., Christmas M.F. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosom Cancer. 13:1995;175-185.
18. Petersen I., Langreck H., Wolf G., Schwendel A., Psille R., Vogt P., Reichel M.B., Ried T., Dietel M. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer. 75:1997;79-86.
19. Schwendel A., Langreck H., Reichel M., Schröck E., Ried T., Dietel M., Petersen I. Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer. 74:1997;86-93.
20. Bjorkqvist A.M., Tammilehto I., Nordling S., Nurminen M., Anttila S., Mattson K., Knuutila S. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer. 77:1998;260-269.
21. Balsara B.R., Sonoda G., Du Manoir S., Siegfried J.M., Gabrielson E., Testa J.R. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res. 57:1997;2116-2120.
22. Petersen I., Bujard M., Petersen S., Wolf G., Goeze A., Schwendel A., Langreck H., Gellert K., Reichel M., Just K., Du Manoir S., Cremer T., Dietel M., Ried T. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res. 57:1997;2331-2335. b.
23. Takahashi T., Obata Y., Sekido Y., Hida T., Ueda R., Watanabe H., Ariyoshi Y., Sugiura T., Takahashi T. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Cancer Res. 49:1989;2683-2688.
24. Liu C., Tsao M.S. In vitro and in vivo expressions of transforming growth factor α and tyrosine kinase receptors in human non-small-cell lung carcinomas. Am J Pathol. 142:1993;1155-1162.
25. Wodrich W., Volm M. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis. 14:1993;1121-1124.
26. Solder A.I., Hoare S.F., Muir S., Going J.J., Parkinson E.K., Keith W.N. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene. 14:1997;1013-1021.
27. Tanner M.M., Tirkkonen M., Kallioniemi A., Isola J., Kuukasjärvi T., Collins C., Kowbel D., Guan X., Trent J., Gray J.W., Meltzer P., Kallioniemi O.P. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. Cancer Res. 56:1996;3441-3445.
28. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu J., Harshman K., Tavtigian S.V., Stocjert E., Day R.S., Johnson B.E., Skolnick M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 264:1994;436-440.
29. INK4a expression in resected non-small cell lung tumors. Cancer Res. 56:1996;3415-3420.
30. Gazzeri S., Gouyer V., Vourc'h C., Brambilla C., Brambilla E. Mechanisms of p16INK4A inactivation in non small cell lung cancers. Oncogene. 16:1998;497-504.
31. INK4a is frequently lost in small cell lung cancer. Cancer Res.
32. Gouyer V., Gazzeri S., Brambilla E., Bolon I., Moro D., Perron P., Benabid A.L., Brambilla C. Loss of heterozygosity at the rb locus correlates with loss of rb protein in primary malignant neuro-endocrine lung carcinomas. Int J Cancer. 58:1994;818-824.
33. Cagale P.T., El-Naggar A.K., Xu H.J., Hu S.X., Benedict W.F. Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Am J Pathol. 150:1997;393-400.
34. Tamura K., Zhang X., Murakami Y., Hirohashi S., Xu H.J., Hu S.X., Benedict W.F., Sekiya T. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int J Cancer. 74:1997;45-49.
35. Wooster R.et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 328:1995;789-792.
36. Naylor S.L., Johnson B.E., Minna J.D., Sakaguchi A.Y. Loss of heterozygosity of chromosome 3 markers in small-cell lung cancer. Nature. 329:1987;451-454.
37. Todd S., Franklin W.A., Varella-Garcia M., Kennedy T., Hilliker C.E., Hahner L., Anderson M., Wiest J.S., Drabkin H.A., Gemmill R.M. Homozygous deletions of human chromosome 3p in lung tumors. Cancer Res. 57:1997;1344-1352.
38. Sozzi G., Veronese M.L., Negrini M., Baffa R., Cotticelli M.G., Inoue H., Tornielli S., Pilotti S., De Gregorio L., Pastorino U., Pierotti M.A., Otha M., Huebner K., Croce C.M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell. 85:1996;17-26.
39. Sanchez-Cespedes M., Rosell R., Pifarre A., Lopez-Cabrerizo M.P., Barnada A., Sanchez J.J., Lorenzo J.C., Abad A., Monzo M., Navas-Palacio J.J. Microsatellite alterations at 5p21, 11p13 and 11p15.5 do not predict survival in non-small cell lung cancer. Clin Cancer Res. 3:1997;1229-1235.
40. Petersen S., Wolf G., Bockmühl U., Gellert K., Dietel M., Petersen I. Allelic loss on chromosome 10q in human lung cancer. association with tumor progression and metastatic phenotype Br J Cancer. 77:1998;270-276.
41. Fong K.M., Zimmerman P.V., Smith P.J. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer. Cancer Res. 55:1995;220-223.
42. Taguchi T., Zhou J.Y., Feder M., Litwin S., Klein-Szanto A.J.P., Testa J.R. Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes. Cancer Genet Cytogenet. 89:1996;120-125.
43. Shiraishi M., Noguchi M., Shimosato Y., Sekiya T. Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res. 49:1989;6474-6479.
44. Yeung R.S., Bell D.W., Testa J.R., Mayol X., Baldi A., Grana X., Klinga-Levan K., Knudson A.G., Giordano A. The retinoblastoma-related gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene. 8:1993;3465-3468.
45. Brambilla E., Negoescu A., Gazzeri S., Lantuejoul S., Moro D., Brambilla C., Coll J.L. Apoptosis-related factors p53, Bc12, and Bax in neuroendocrine lung tumors. Am J Pathol. 149:1996;1941-1952.
46. Jiang S.X., Kameya T., Sato Y., Yanase N., Yoshimura H., Kodama T. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differenciation. Am J Pathol. 148:1996;837-846.
47. Nishio H., Nakamura S., Horai T., Ikegami H., Matsuda M. Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer. Cancer. 69:1992;1130-1136.